Answers are grounded in this paper and cite their sources.
Sedation is a known adverse effect of risperidone, but catatonia-like immobility potentiated by valproate is rarely reported. A 23-year-old woman with bipolar disorder, admitted for acute psychosis, was treated with risperidone titrated to 3 mg twice daily alongside valproate. She developed escalating somnolence, immobility, refusal of food, and tremors. Laboratory evaluation revealed a supratherapeutic valproate level (125 µg/mL); medical workup and a lorazepam challenge were unrevealing. Discontinuation of risperidone with substitution with olanzapine resulted in rapid and complete recovery within 24 hours. This case highlights the risk of severe catatonia-like sedation from a risperidone-valproate interaction. It underscores the importance of recognizing medication-induced causes of catatonia-like presentations to enable timely intervention.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: